搜索临床试验以:索拉非尼(BAY43-9006,多吉美)
总计442个结果
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)M.D. Anderson Cancer Center撤销黑色素瘤 | 复发性黑色素瘤 | IV 期黑色素瘤 | III期黑色素瘤
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma黑色素瘤 | 复发性黑色素瘤 | IV 期黑色素瘤 | III期黑色素瘤美国
-
University of Zurich完全的黑色素瘤 III 期或 IV 期 | No Prior Chemotherapy瑞士
-
Accelerated Community Oncology Research NetworkBayer终止
-
Amsterdam UMC, location VUmc完全的
-
Suleiman MassarwehBayer终止
-
Mahidol UniversityBayer完全的
-
National Cancer Institute (NCI)主动,不招人III 期皮肤黑色素瘤 AJCC v7 | IV 期皮肤黑色素瘤 AJCC v6 和 v7 | 晚期恶性实体瘤 | 难治性恶性实体瘤 | 复发性黑色素瘤 | IIIC 期皮肤黑色素瘤 AJCC v7 | IIIA 期皮肤黑色素瘤 AJCC v7 | IIIB 期皮肤黑色素瘤 AJCC v7美国
-
Stanford University完全的
-
Technische Universität DresdenBayer完全的
-
Roswell Park Cancer InstituteBayer完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
University of Pennsylvania完全的
-
Egyptian Society of Liver Cancer终止
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
Chinese Society of Lung Cancer完全的
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)终止岛状甲状腺癌 | 复发性甲状腺癌 | IV 期滤泡性甲状腺癌 | IV 期乳头状甲状腺癌 | 未分化甲状腺癌 | III 期滤泡性甲状腺癌 | III 期乳头状甲状腺癌美国
-
Indiana University School of MedicineBayer完全的骨髓增生异常综合征 | 白血病,骨髓,急性 | 白血病,早幼粒细胞,急性美国
-
NYU Langone HealthBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma终止
-
Italian Trial in Medical Oncology完全的
-
M.D. Anderson Cancer CenterBayer完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的复发性肾细胞癌 | III 期肾细胞癌 AJCC v7 | IV 期肾细胞癌 AJCC v7美国
-
National Cancer Centre, Singapore终止
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的